Evelo Biosciences Inc

Evelo Biosciences Inc is a US-based biotechnology company operating primarily in North America. It focuses on developing oral medicines that target the gut to treat a range of diseases. Operating within the biopharmaceutical sector, Evelo Biosciences Inc develops therapies leveraging its proprietary platform to modulate the gut-body network. Its pipeline includes treatments for inflammatory, autoimmune, and oncology-related conditions. The company collaborates with research institutions and industry partners to advance its clinical programs. Explore EVLO share prices and other stocks on eToro to stay up to date. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.